Učitavanje...
Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease
Preclinical and clinical evidence suggests that docosahexaenoic acid (DHA), an omega-3 fatty acid derived from diet or synthesized in the liver, decreases the risk of developing Alzheimer's disease (AD). DHA levels are reduced in the brain of subjects with AD, but it is still unclear whether hu...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3161165/ https://ncbi.nlm.nih.gov/pubmed/21543199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.plefa.2011.04.021 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|